PD45-12: Sexual and functional outcomes after trans-urethral incision of the prostate: a long term follow up analysis

Riccardo Lombardo*, Antonio Maria Cicione, Rome, Italy, Antonio Nacchia, Rionero in Vulture, Italy, Carmen Gravina, Beatrice Turchi, Jordi Stira, Simone D'Annunzio, Lorenzo Maria Rivesti, Alessandro Guercio, Giorgio Guarnotta, Antonio Franco, Giacomo Gallo, Elisa Mancini, Olivia Alessandra Voglino, Valeria Baldassarri, Sara Riolo, Andrea Tubaro, Cosimo De Nunzio, Rome, Italy

Introduction: Long term data on functional and sexual outcomes after transurethral monoliteral incision of the prostate is poor. Aim of our study is to evaluate long term functional and sexual outcomes in patients undergoing transurethral incision of the prostate (TUIP).

Methods: A retrospective analysis of patients with LUTS and undergoing TUIP in our centre between 2011 and 2016 was performed. All patients underwent monolateral incision of the prostate. Demographic and clinical data was recorded. All patients were reassessed in September 2021 with medical history, IPSS, PSA, maximal urinary flow rate (Qmax), post void residual urine (PVR). Erectile function was evaluated with the SHIM score and ejaculatory function with sfMSHQ score. Reoperated patients were excluded from the analysis.

Results: Overall 92 patients were enrolled with a median age of 53 years and a median PV of 27 cc. Median follow up was 75 months. At end of follow up median IPSS was 9 (6/13), median PSA was 0,6 (0,51/0,89) and median Qmax was 15 (12/17). Moderate/severe symptoms (IPSS>8) were recorded in 59/92 (64%) patients and poor flow in 40/92 (44%). Moreover 6 (7%) patients required reintervention and 25/92 (25%) were on medications. Regarding sexual function median SHIM score was 22 (16/25) and median MSHQsf was 14 (12/15). Moreover only 6/92 (7%) patients presented aneiaculation. None of the preoperative variable was find to be a predictor of poor outcome.

Conclusions: According to our single center study, patients after monolateral TUIP a have a good sexual function even in the long term. However, half of the patients present moderate symptoms and poor flow.

Source of Funding: None.